> Natera recently brought to market a non-invasive pre-natal test that can detect Down syndrome and other conditions in a mother’s blood. Previously, testing for these conditions required a risky procedure that extracted tissue from the fetus. Other non-invasive tests aren’t as comprehensive.

> Because Natera's test is better than its competitors' products, the company charges more.

> “Premium pricing communicates a premium product,” says Matthew Rabinowitz, the company’s CEO.

Is this normal in the USA? Talking of "premium offerings" in the context of healthcare seems sickening to me. Premium hospital beds with high speed broadband, alrighty, but premium healthcare itself? I understand that one needs to recoup R&D costs a few times over for it to be worth the risk, but that's simply cost price (risk * R&D cost / unit count * unit cost) and not a "premium product". This isn't a non-essential premium Ferrari, it could help a lot of people. Is it just me who finds this a really weird example?